chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 14 year old female who was vaccinated with her first 0.5 ml dose of GARDASIL towards the latter part of last year. The patient had a seizure "a couple days" after getting GARDASIL and had "several" seizures since then. The doctor's nurse said that the patient's father checked with a neurologist who said that the seizures were linked to GARDASIL. The outcome is unknown. The patient sought medical attention. Upon internal review, seizure was determined to be an other important medical event. Additional information has been requested.
Patient said two days after her first dose she experienced "profound hearing loss" in her right ear, as well as tinnitus. Joint pain started about 5 to 6 days after the hearing loss. She has visited her doctor, ENT specialist, and surgeon, who has been giving her cortisone shots in her ear.
PHN accidentally failed to dilute orange cap Pfizer 5-11 year old vaccine. Dose given was 0.2mL of undiluted vaccine.
Swelling in face. Breathing issues for first couple days. That cleared up, but the chest pain has stayed with me from the day I started to have the reaction.
The day after having my first dose my right arm had soreness and discomfort. Then following my second dose my right arm has now been experiencing numbness & tingling for the past three days consistently.
I am experiencing a fever of a 100.8; I have very low vision; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (reported as COVID-19 shot), via an unspecified route of administration on 22Jan2021 17:00 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient stated "I had the COVID shot last evening around 5 o' clock (22Jan2021 17:00) and now today (23Jan2021) I am experiencing a fever of a 100.8 and I wondered, I don't read well because I have very low vision, so I have to speak to someone, they gave me paper, but I can't read them. So, if you could tell me what I could do for the fever?" The outcome of the events was unknown.    Information on the lot/batch number has been requested.
Intense unexplained itching. No rash, hives, bumps, or lesions on skin at any time. Cannot control itch, have no other symptoms. Have seen countless doctors and nothing is working. This has been going on for 7 months.
Patient admitted to the hospital for abdominal pain/Small bowel obstruction with incidental finding of +COVID-19 test. Per MCIR, patient received two doses of the Moderna COVID-19 vaccine, 1st on 1/30/21 and 2nd on 2/27/21.
Quarter-size red blue lesion (R) thigh on 11/17/07. Returned to office on 11/19/07 with macular rash over most of body.
Blistering on mucosal skin consistent with autoimmune phenomena seen before in patient when immune system is hyperactive.
Hoarseness, scratchy throat, runny nose, rash on left arm and small rash on stomach. Pain in left arm, swelling
Alternating chills and sweating.  Cold toes that could not be warmed up with heating pad.    Eventually, ?fluttering? sensation in legs (worse at night) and sometimes in stomach and arms, repeated hypnic jerks at night, numbness in extremities, shooting ?electric-like? pain in hand, fingers and toes.  Nerve-like pain in arms and legs. Extreme weakness arms and legs.  Burning sensation in hips.  Pain in right leg and thigh.  Pain in shoulders radiating down arm mostly on the right side.
Anxiety Attacks, Chest Palpation, Chest Aches, Chronic Fatigue, Heart Muscle Pain, Chest Pain, Dizziness Spells
Pt. experienced some difficulty breathing. At the injection site, severe erythema and swelling occurred.
This spontaneous report was received from a registered nurse and refers to an 1-day-old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 20-OCT-2018, the patient was vaccinated with improperly stored dose of LIQUID PEDVAXHIB lot # R014261, expiration date 25-MAR-2021 or lot # R005118, expiration date 28-NOV-2020 (dose and route of administration were not reported).  Administered dose of vaccine experienced the temperature excursion of 31.1 Fahrenheit degrees (F) (below 32 F/ 0 Celsius degrees) (30 cycles) for 35 hours 30 minutes. There were no previous excursions reported. The digital data logger was involved to capture the temperature excursion. No adverse effects were reported. This is one of multiple reports received from the same reporter (it was reported that it was unknown which lot numbers of each specific vaccine were administered to which patient).; Sender's Comments: US-009507513-1901USA000071:
Progressive LE ascending weakness/paresthesias with clinical evidence of Guillain Barre syndrome requiring hospitalization/IVIg plus plasma exchange.
About 12 hours after receiving the booster shot, I woke up in the middle of the night with sharp pain on my left side under my arm. It was very swollen and painful for 1 week and improved slightly at that point but still too painful to put any pressure on that side or lay on that side for another 3 weeks. I started taking Benadryl to try to help but the pain continued for about 7 weeks after the shot.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Hypotension-Medium
Hospitalization unrelated to COVID, tested at d/c prior to d/c to SNF.
12/20/21 presents to ED for "dyspnea". PMHx of "renal transplant Aug 2021, CKD secondary to FSGS, SLE, pulmonary fibrosis, hepatitis B, CAD, CVA, HTN, HLD"
Symptoms of extreme depression, anxiety, irritability, emotional distress, breast tenderness, insomnia, night sweats, nervousness, feeling overwhelmed, onset of extremely blurred vision and then only slightly blurred, sudden onset vertigo for short period of time, brain "fog" periodically.
Patient vomited about 3 hours after ROTATEQ was given. It was a projectile vomit. Patient then vomited again within a minute. No more episodes of vomiting occurred. No diarrhea.
On March 16 the patient sent a letter to the pharmacy regarding her reaction to the shot: Lethargic on the first day. On the second day, body pain, loss of appetite, fever, chills. She notes excruciating pain in left arm pit which radiated down the side of her body and left arm that lasted 15 minutes. Rash and redness at site of injection. After a week she notes of improvement in redness of rash with increased itching . Fatigue lasting about one week.
On 03/07/2023 in the morning I went to my doctor's office because I was having allergy symptoms. I was also congestion in my upper chest. I did a COVID-19 home test which was negative. The next day 03/08/2023 I tested positive for COVID-19 infection using a home test. I had fever of 99.05 for 1 day, I was tired, congested,   body aches, and I a mild cough.  I called my doctor's office because I was scared and wasn't sure if I needed Paxlovid.  I explained  my symptoms since it wasn't severe. I didn't get Paxlovid  because my doctor said I was health instead he prescribe Steroids  pack  for allergies. I tested positive for 10 days . I tested negative for  COVID-19  by 03/20/2023.
Patient received ZOSTAVAX vaccine and had a red rash occur immediately after the injection with itching. Patient had filled out a form and stated she had no allergies.
Pt reports onset on nausea and palpitations approximately 10 hours after receiving first dose of vaccine. Pt reports Emergency room visit, where she states she was diagnosed with atrial fibrillation. Pt reports she underwent 3 days of hospitalization, converting spontaneously without treatment to normal sinus rhythm.
UTI before second dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URINARY TRACT INFECTION (UTI before second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced URINARY TRACT INFECTION (UTI before second dose). At the time of the report, URINARY TRACT INFECTION (UTI before second dose) outcome was unknown.            No relevant concomitant medications reported. Treatment information include nitrofurantoin. Action taken with mRNA-123 is not applicable.
Information hs been received from a physician and a licensed practical nurse concerning a female patient who was recently vaccinated with the second dose of VARIVAX (Oka/Merck). Subsequently the patient experienced redness at the injection site, swelling at the injection site and cellulitis. At the time of the report the patient had recovered from the redness and swelling at the injection site. The patient sought unspecified medical attention. This is one of several reports received from the same source. Additional information has been requested.
Swelling in her legs, "It wasn't severe, it was noticeable to me but it wasn't severe"; More than 36 days after the first dose without receiving the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling in her legs, "It wasn't severe, it was noticeable to me but it wasn't severe") and PRODUCT DOSE OMISSION ISSUE (More than 36 days after the first dose without receiving the second dose) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 36 days after the first dose without receiving the second dose). On an unknown date, the patient experienced PERIPHERAL SWELLING (Swelling in her legs, "It wasn't severe, it was noticeable to me but it wasn't severe"). On 09-Mar-2021, PRODUCT DOSE OMISSION ISSUE (More than 36 days after the first dose without receiving the second dose) had resolved. At the time of the report, PERIPHERAL SWELLING (Swelling in her legs, "It wasn't severe, it was noticeable to me but it wasn't severe") had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  The patient did not receive any treatment for the swelling. The patient had an ultrasound done at her veins and they were normal. The patient experienced some swelling in her legs that lasted for about 1 month and a half.
Patient started having  frequent arm pain. It comes on suddenly and lasts a few minutes.  Started within a month of the vaccine 2/2021.   The location is the site of her last immunization in her left upper arm.. It is a throbbing sometimes sharp pain in the site. Today it went down her side of the arm to the elbow with tingly purplish fingers.
8 days post shot was extremely tender and had not been except first 24 hours, then 10 days after shot a horrible bright red patch around shot site
On day 13 (2/5/2021) I noticed a penny size red rash spot on my left mid-upper arm about 2-1/2" below where the vaccine was administered.   On day 14 (2/6/2021) I noticed that the red rash had spread from the penny size area to include another attached bigger surface area the size of medium plum and is slightly itchy.  I took a Clairtin the evening of day 14.  On day 15 both the penny size area and the plum area were increased to a slightly bigger surface area.
Pt initially felt no pain when vaccine administered on Friday 10/9/15. Sunday 10/11/15 in the evening arm started to hurt. By Monday patient was in "agony" and saw physician. Pt said she couldn't move her arm without pain at this time. Pain also sometimes radiates through shoulder into neck. MD prescribed muscle relaxant and Tylenol with codeine. Pt did not take Tylenol with codeine but did take muscle relaxant at night and took 600 mg of ibuprofen which she said helped. Spoke with patient on Wed 10/14 and again on Thurs 10/15/15. She said pain is getting lesser every day but still present somewhat. Advised massaging the muscle, moving it as much as possible and icing it if necessary.
Left foot became tingly as if it had fallen asleep starting at around 8:00 pm the evening of the injection. I was sitting on the couch with my legs outstretched and crossed at the ankle in front of me. I thought it was because I had my legs crossed. I uncrossed them. The feeling did not go away. It is now the next day and the feeling is still present. I sit this way often and have never had this happen before. I assume it is due to the vaccine.  It is extremely weird to feel pins and needles constantly in your foot.
I had no adverse reaction to the first Pfizer Covid-19 shot administered on 1/28/2021. On Feb. 18, 2021, I received my second Pfizer Covid-19 vaccination.  I had the common side effects of fatigue and aching for about 24-48 hours which resolved with no further difficulties.  Around 4-6 weeks post Pfizer #2, I began to have significant Very Loud uptick of tinnitus symptoms.  I have a 35 year history of VERY mild, tolerable tinnitus (completely habituated and non bothersome) associated with sensorineural hearing loss.  I reported this to my personal physician who denied association with the vaccine.  I then went to see my Otolaryngologist who stated she didn't know if it was associated with the vaccine, but had heard from a couple of patients with similar experiences.   I also went and had my hearing acuity checked by my Audiologist, who also was at a loss regarding this sudden exacerbation of tinnitus.  My hearing was tested and is stable so it is not associated with further hearing loss.  All involved professionals are stating that they do not have any remedies to cure this condition.  After 9 months I continue to experience severe tinnitus 24/7.   This has created a significant life challenge, and negative impact upon my life quality.  I am seeking answers.
Patient called on 5/19/21 and spoke with pharmacist, he indicated that on 5/17/21 he noticed the skin around the injection site was abnormal. Patient described the site as being black in color, painful and swollen measuring about an inch in diameter. Patient states he lightly palpated the area and when he removed his finger the skin around the injection site fell off, he says he could "see the meat" underneath the skin; denies presence of pus, blood or other systemic symptoms. Advised the patient to seek medical care right away by going to urgent care. Patient indicated he would, Asked patient to report back to us or we would follow up with him via phone call in a few days to assess outcome and any complications for his second dose of the vaccine series.
Patient received her immunization with ZOSTAVAX on 8/29/17. She reported having swelling, itchiness, and painful sensation at the site of vaccination a day later (8/30/17). Patient presented at the pharmacy on 8/31/17 with the presentation of a large erythematous rash at the site of immunization. The area appeared red, raised, and warm when palpitated. The diameter of her swollen rash was approximately 6 inches. Patient denied having symptoms of difficulty breathing, faintishness, or swelling of her throat. Patient's primary care provider was contacted about the incident through his case manager. The patient was provided with hydrocortisone cream 1 (CORTIZONE-10) and cetirizine 10 mg to resolve her symptoms. Patient was informed that she could visit her primary care provider's office but she declined from doing so since she is going on her trip on the same day. If her symptoms worsen, she was informed to contact Dr.
suspected vaccination failure; got it; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient had the shingles shot and experienced shingles anyway and it was so bad. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
Had bad flu like symptoms - chills, muscle aches, joint aches, nauseous, fatigue, difficulty concentrating   Took ibuprofen   Most symptoms subsided after 24 hours but still having some muscle and joint aches
Headache, body ache, fever and chills, exhaustion, all experienced off and on for the two days following my vaccination.
Patient arrived for her Janssen Booster Appt. and after patient education decided to receive a Moderna Booster. In the observation area she began having itching and redness on both arms and hands. Pt?s VS were evaluated, and the patient asked for and was administered Benadryl PO. The patient, at no time, exhibited signs of shortness of breath, swelling or Anaphylaxis. The itchy, red rash was only on her arms and palms. Pt was asked to stay for a full 30 minutes of observation and offered EMS if desired.  Pt Hx of HTN, Diabetes. Allergy to Mangos.  Pt VS Prior to Benadryl 1825-BP 154/81 P 69 reg R 12 unlabored, SPO2 98% RA 1832- Benadryl PO 1842- BP 127/86 P 67 reg R14 unlabored, SPO2 98% RA, Rash and Itchiness starting to subside. Pt offered EMS but respectfully declined. She was advised to call 911 if severe symptoms occur and to follow up with Benadryl and her Doctor as needed. Pt left the vaccination Center at approximately 1850 hrs.
Fever (100-103° F for ~36 hrs), chills (~36 hrs) muscles aches (~48 hrs), headache (~72 hrs), rash/swelling to upper arm distal to injection site (~48 hrs after vax admin, ~2? x 3?, present for ~1wk)
MRI after first dose, 5mm growth on lungs; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY MASS (MRI after first dose, 5mm growth on lungs) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 004M20A) for COVID-19 vaccination.     Concurrent medical conditions included Crohn's disease.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PULMONARY MASS (MRI after first dose, 5mm growth on lungs). At the time of the report, PULMONARY MASS (MRI after first dose, 5mm growth on lungs) had not resolved.            No treatment information was provided.  Action taken with the mRNA-1273 in response to the event is not applicable.   This case was linked to MOD-2021-138893 (Patient Link).
Patient had previously received dose of Janssen on 03/20/21-  Patient states he feels fine just tired
Feet swelling; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Feet swelling) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Feet swelling). At the time of the report, PERIPHERAL SWELLING (Feet swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products were reported.  No treatment information was provided.
seizures  high fever   rash then dots all over   very sleepy    not hungry    very weak         still not feeling well   Motrin every four hours
Patient was given her 2nd dose of shingrix to her (R) deltoid. After a minute of administered, her (R) swells up on where the site was given. Provider were in presence to observe and ordered Solu-Medrol for patient. Patient stated the arm just hurts and nothing more. No other side effects were known. After 15 mins of waiting, swelling went down.
Fine papular rash appeared on cheeks then spread to trunk, neck, bottom, legs and all of face throughout the week 1/16/11 thru 1/24/2011.  Seen Physician Dr on 1/25/2011 and child was started on Zyrtec and Amoxicillin.
The patient is experiencing a rash on her arm and it is warm. The doctor marked the lines of the rash and instructed her to keep an eye out and see if it gets better. She will follow up with the doctor and with us.
On 6/21/00, left arm began to swell from shoulder to hand and including hand; also, had redness in tricep area but not red on 6/22/00. Difficulty lifting arm up over head or bending at elbow. Upper arm "tight" with swelling and painful. Afebrile. MD checked child on 6/22/00 at 09:00.
Patient reports fever, chills, redness & pain to injection site, and slight dizziness. Treated with BENADRYL, ibuprofen, warm compress.
This spontaneous report has been received from a 56 year old female consumer. None concurrent conditions, pertinent medical history or drug reactions/allergies were reported. On 23-NOV-2015, the patient was vaccinated with a dose of ZOSTAVAX lot # L012039, exp date on 07-JUL-2016, 0.65 ml, subcutaneous in her right arm. The patient concomitantly received the influenza virus vaccine (product name unspecified) in the opposite arm (left arm) on an unspecified date in 2015. On 24-NOV-2015, the patient noticed that she had developed redness and there was a "hard lump about the size of an egg" around the ZOSTAVAX injection site and it also felt warm to the touch. The patient did not seek medical attention. Therefore, no laboratories were performed and there was no treatment given for the adverse events. There was no hospitalization or prolonged. At the reporting time, the patient present status was reported as not recovered. The causal assessment of injection site lump, injection site warmth and injection site redness to ZOSTAVAX was not reported. Additional information has been requested.
Patient reports she began to feel "dizzy" as she entered the observation area after receiving her second dose of the vaccine. Assisted patient to EMS room for closer observation. After 10 minutes, patient reports, "I'm fine." Escorted her to the front door.